Grifols SA (GRFS)
9.15
-0.07
(-0.76%)
USD |
NASDAQ |
Feb 11, 12:58
Grifols Price : 9.15 for Feb. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biodexa Pharmaceuticals Plc | 1.21 |
| Akari Therapeutics Plc | 0.249 |
| Pharma Mar SA | 88.72 |
| Autolus Therapeutics Plc | 1.41 |
| Oryzon Genomics SA | 3.60 |
Price Related Metrics
| PE Ratio | 14.90 |
| PS Ratio | 0.7488 |
| PEG Ratio | 0.0897 |
| Price to Book Value | 2.702 |
| Price to Free Cash Flow | 8.031 |
| Earnings Yield | 6.71% |
| Market Cap | 6.227B |
| PEGY Ratio | 0.0887 |
| Operating PE Ratio | 4.140 |
| Normalized PE Ratio | 15.67 |